FDA OKs Genentech drug for early breast cancer
(Reuter


<p><a href="http://us.rd.yahoo.com/dailynews/rss/health/*http://news.yahoo.com/s/nm/20061117/hl_nm/genentech_herceptin_dc"><img src="http://d.yimg.com/us.yimg.com/p/nm/20061117/2006_11_16t181813_450x300_us_genentech_herceptin.jpg?x=130&y=86&sig=9DEbxoz4I6QjIDqvph9WSQ--" align="left" height="86" width="130" alt="A vial and pack of Herceptin are seen in London June 9, 2006. The U.S. Food and Drug Administration has agreed to expand the use of Genentech Inc.'s breast cancer drug Herceptin to include women with early-stage cancer who have undergone surgery, the company said on Thursday. (Luke MacGregor/Reuters)" border="0" /></a>Reuters - The U.S. Food and Drug
Administration has expanded the use of Genentech Inc.'s breast
cancer drug Herceptin to include women with early stage cancer
who have undergone surgery, the biotechnology company said on
Thursday.</p><br clear="all"/>